At close: January 3 at 5:35:49 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 16 | 23 | 26 |
| Avg. Estimate | 21.94B | 22.33B | 87.79B | 91.72B |
| Low Estimate | 21.66B | 21.98B | 87.25B | 87.89B |
| High Estimate | 22.43B | 24.23B | 88.8B | 94.67B |
| Year Ago Sales | 21.74B | 22.1B | 87.7B | 87.79B |
| Sales Growth (year/est) | 0.91% | 1.03% | 0.11% | 4.47% |
EPS Trend
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FDX.DE | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Raymond James: Outperform to Outperform | 12/20/2024 |
| Maintains | B of A Securities: Buy to Buy | 12/20/2024 |
| Maintains | BMO Capital: Market Perform to Market Perform | 12/20/2024 |
| Maintains | Stephens & Co.: Overweight to Overweight | 12/20/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 12/20/2024 |
| Maintains | Stifel: Buy to Buy | 12/20/2024 |